Karolinska company eyes IPO
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article9090157.ece/ALTERNATES/schema-16_9/Karolinska%2520Development%2520logo.jpg)
The Swedish biotech company Dilaforette seems to be ready for the next stage in its development and investment group Karolinska Development, which owns the company, has informed the market about a number of changes.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Karolinska launches new venture initiative
For abonnenter
Karolinska company in record-breaking financing round
For abonnenter
Karolinska injects millions in Danish medtech company
For abonnenter